Management of Subretinal Hemorrhage in Age-related Macular Degeneration – Case Report.

Wydanie 2/2021
str. 68 – 71

Autorzy: Michał Chrząszcz^1,2, Katarzyna Żuber-Łaskawiec^1,2, Jakub Jarczak², Bożena Romanowska-Dixon^1,2, Izabella Karska-Basta^1,2.

1 Katedra Okulistyki Uniwersytetu Jagiellońskiego Collegium Medicum Klinika Okulistyki i Onkologii Okulistycznej Szpitala Uniwersyteckiego w Krakowie
Kierownik: prof. dr hab. n. med. Bożena Romanowska-Dixon
2. Oddział Kliniczny Okulistyki i Onkologii Okulistycznej Szpitala Uniwersyteckiego w Krakowie
Kierownik: prof. dr hab. n. med. Bożena Romanowska-Dixon

Summary: 

Subretinal macular hemorrhage in wet age-related macular degeneration poses a high risk of severe visual impairment. Prolonged subretinal hemorrhage ultimately leads to a discoid scar in the macula and irreversible loss of central vision. In the following study, we present a case report of a patient who was treated with intravitreal injection of recombinant tissue plasminogen activator and sulfur hexafluoride. As a result of the applied treatment, the visual acuity and anatomical parameters of the retina improved which was confirmed by optical coherence tomography examination.

Because of lack of the gold standard of care in patients with subretinal hemorrhages in the course of the wet age-related macular degeneration further observations and analyzes of the applied therapies in this group of patients are needed.